Rouault Eline, Lecoeur Hervé, Meriem Asma Ben, Minoprio Paola, Goyard Sophie, Lang Thierry
Institut Pasteur, Département d'Infection et d'Epidémiologie, Laboratoire des Processus Infectieux à Trypanosomatidés, 25 rue du Dr Roux, 75724 Paris cedex 15, France.
Institut Pasteur, Département d'Infection et d'Epidémiologie, Laboratoire des Processus Infectieux à Trypanosomatidés, 25 rue du Dr Roux, 75724 Paris cedex 15, France.
Parasitol Int. 2017 Feb;66(1):933-939. doi: 10.1016/j.parint.2016.10.020. Epub 2016 Oct 26.
Characterizing the clinical, immunological and parasitological features associated with visceral leishmaniasis is complex. It involves recording in real time and integrating quantitative multi-parametric data sets from parasite infected host tissues. Although several models have been used, hamsters are considered the bona fide experimental model for Leishmania donovani studies. To study visceral leishmaniasis in hamsters we generated virulent transgenic L. donovani that stably express a reporter luciferase protein. Two complementary methodologies were combined to follow the infectious process: in vivo imaging using luciferase-expressing Leishmania and real time RT-PCR to quantify both Leishmania and host transcripts. This approach allows us: i) to assess the clinical outcome of visceral leishmaniasis by individual monitoring of hamster weight, ii) to follow the parasite load in several organs by real time analysis of the bioluminescence in vivo and through real time quantitative PCR analysis of amastigote parasite transcript abundance ex vivo, iii) to evaluate the immunological responses triggered by the infection by quantifying hamster transcripts on the same samples and iv) to limit the number of hamsters selected for further analysis. The overall data highlight a correlation between the transcriptional cytokine signatures of hamster affected tissues and the amastigote burden fluctuations, thus providing new insights into the immunopathological process driven by L. donovani in the tissues of mammalian hosts. Finally, they suggest organ-specific immune responses.
表征与内脏利什曼病相关的临床、免疫和寄生虫学特征十分复杂。这涉及实时记录并整合来自寄生虫感染宿主组织的多参数定量数据集。尽管已使用多种模型,但仓鼠被认为是杜氏利什曼原虫研究的正宗实验模型。为了在仓鼠中研究内脏利什曼病,我们构建了稳定表达报告荧光素酶蛋白的强毒转基因杜氏利什曼原虫。我们结合了两种互补方法来跟踪感染过程:使用表达荧光素酶的利什曼原虫进行体内成像,以及使用实时逆转录聚合酶链反应(RT-PCR)来定量利什曼原虫和宿主转录本。这种方法使我们能够:i)通过单独监测仓鼠体重来评估内脏利什曼病的临床结果;ii)通过体内生物发光的实时分析以及体外对无鞭毛体寄生虫转录本丰度的实时定量PCR分析,跟踪多个器官中的寄生虫载量;iii)通过对相同样本中的仓鼠转录本进行定量,评估感染引发的免疫反应;iv)限制选择用于进一步分析的仓鼠数量。总体数据突出了受影响仓鼠组织的转录细胞因子特征与无鞭毛体负荷波动之间的相关性,从而为杜氏利什曼原虫在哺乳动物宿主组织中驱动的免疫病理过程提供了新见解。最后,这些数据表明存在器官特异性免疫反应。